Início › Câncer de Pulmão de Células Pequenas › Tennessee

Ensaios clínicos de Câncer de Pulmão de Células Pequenas em Tennessee

24 estudos para Câncer de Pulmão de Células Pequenas estão buscando participantes em locais em Tennessee.

Cidades em Tennessee

Texto oficial do estudo (Inglês)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Sarah Cannon Research Institute, Nashville

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Sarah Cannon Research Institute - Pharmacy, Nashville
SCRI Oncology Partners, Nashville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT03460977

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Sarah Cannon Research Institute (SCRI), Nashville

RecrutandoFase 1

Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Baptist Cancer Center - Memphis, Memphis

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07472517

DESTINY-PANTUMOUR04

Research Site, Nashville

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Vanderbilt University Medical Center, Nashville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road /ID# 280619, Knoxville
University Of Tennessee Medical Center /ID# 279896, Knoxville
Baptist Memorial Hospital /ID# 281405, Memphis
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07365241

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Sarah Cannon - Tennessee Oncology, Nashville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

SCRI Oncology Partners, Nashville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07325136

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

SCRI OP (Oncology Partners), Nashville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07218146

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

SCRI Oncology Partners, Nashville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06646276

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Sarah Cannon Research Institute ( Site 7001), Nashville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06780137

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

West Cancer Center & Research Institute, Germantown
University of Tennessee Medical Center, Knoxville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06712355

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

SCRI Oncology Partners, Nashville

RecrutandoFase 1/2

Idades de 18 a 100 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT06726148

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Sarah Cannon Research Institute (SCRI), Nashville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07488923

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

Baptist Cancer Center, Memphis

RecrutandoFase 1

Idades de 18 a 99 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT07531095

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

SCRI Oncology Partners, Nashville

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06095505

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

THE WEST CLINIC, PLLC dba West Cancer Center, Germantown

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06203210

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

Tennessee Oncology, PLLC, Nashville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de jul. de 2026 · NCT06931626

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Sarah Cannon Research Institute - Pharmacy, Nashville
SCRI Oncology Partners, Nashville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT06131840

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Sarah Cannon Research Institute - Oncology Partners, Nashville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT07174583

A Study of LY4175408 in Participants With Advanced Cancer

Sarah Cannon Research Institute, Nashville

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT07046923

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 136, Nashville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de nov. de 2025 · NCT05914116

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.